Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Current price
11.21 USD -0.93 USD (-7.66%)
Last closed 11.82 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 896 418 USD
Yield for 12 month +3.08 %
1Y
3Y
5Y
10Y
15Y
CVKD
21.11.2021 - 28.11.2021

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida. Address: 822 A1A North, Ponte Vedra, FL, United States, 32082

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

52.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-1 980 USD

Last Year

-1 266 USD

Current Quarter

-470 USD

Last Quarter

-597 USD

Key Figures CVKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 626 399 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -91.9 %
PEG Ratio
Return On Equity TTM -174.01 %
Wall Street Target Price 52.5 USD
Revenue TTM
Book Value 3.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -4.8 USD
Diluted Eps TTM -4.8 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CVKD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CVKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 20.08.2024
Dividend Date

Stock Valuation CVKD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.2128
Price Book MRQ 2.7294

Financials CVKD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CVKD

For 52 weeks

5.4 USD 32.55 USD
50 Day MA 7.13 USD
Shares Short Prior Month 60 059
200 Day MA 8.85 USD
Short Ratio 0.41
Shares Short 15 819
Short Percent 2.66 %